Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.

Authors :: Berger, M. G.
Berger, J.
Richard, C.
Jeanpierre, S.
Nicolini, F. E.
Tournilhac, O.
Michallet, M.
Maguer-Satta, V.
Source :: Leukemia (08876924). Nov2008, Vol. 22 Issue 11, p2135-2135. 1p.
Publication Year :: 2008
Abstract: A correction to the article "Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization" that was published in a previous issue is presented.

Full Text Access

Tools